Pulmonary Megakaryocytes in Coronavirus Disease 2019 (COVID-19): Roles in Thrombi and Fibrosis

類似資料

• Differentiating biochemical from clinical heparin resistance in COVID-19
  著者:: Lisman, Ton, 等
  出版事項: (2020)
• SARS-2 Coronavirus–Associated Hemostatic Lung Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary Embolism?
  著者:: Thachil, Jecko, 等
  出版事項: (2020)
• Pulmonary rehabilitation for patients with coronavirus disease 2019 (COVID-19)
  著者:: Yang, Lu-Lu, 等
  出版事項: (2020)
• A Fatal Case of Coronavirus Disease 2019 (COVID-19) in a Patient With Idiopathic Pulmonary Fibrosis
  著者:: Rajasurya, Venkat, 等
  出版事項: (2020)
• Coagulopathy of Coronavirus Disease 2019
  著者:: Iba, Toshiaki, 等
  出版事項: (2020)